ES2085163T3 - Vacunas contra los parasitos metazoos. - Google Patents

Vacunas contra los parasitos metazoos.

Info

Publication number
ES2085163T3
ES2085163T3 ES93916110T ES93916110T ES2085163T3 ES 2085163 T3 ES2085163 T3 ES 2085163T3 ES 93916110 T ES93916110 T ES 93916110T ES 93916110 T ES93916110 T ES 93916110T ES 2085163 T3 ES2085163 T3 ES 2085163T3
Authority
ES
Spain
Prior art keywords
parasites
present
presents
type
vaccines against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916110T
Other languages
English (en)
Inventor
William David Smith
Stuart Kevin Smith
Jacqueline Murray
Susan Liddell
David Patrick Knox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Veterinary Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215505A external-priority patent/GB9215505D0/en
Priority claimed from GB929217635A external-priority patent/GB9217635D0/en
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of ES2085163T3 publication Critical patent/ES2085163T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6416—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTAN NUEVOS ANTIGENOS CONTRA PARASITOS METAZOARIOS, ACIDOS NUCLEICOS QUE LOS CODIFICAN Y SU USO PARA EL CONTROL DE ENFERMEDADES PROVOCADOS POR HELMINTOS Y OTROS PARASITOS METAZOARIOS, EN PARTICULAR HELMINTOS Y PARASITOS ARTROPODOS DE ANIMALES DOMESTICOS. EN PARTICULAR, EN LA INVENCION SE PRESENTA UN ANTIGENO CONTRA PARASITOS METAZOARIOS O FRAGMENTOS ANTIGENICOS, COMPONENTES O PRECURSORES DE LOS MISMOS Y LOS DERIVADOS FUNCIONALMENTE EQUIVALENTES, ANALOGOS O VARIANTES DE LOS MISMOS QUE PRESENTAN UNA ACTIVIDAD ANTIGENICA PROTECTORA CONTRA UNO O MAS PARASITOS METAZOARIOS, CUYO ANTIGENO SE CARACTERIZA PORQUE ES CAPAZ DE ENLAZARSE A LA PEPSTATINA Y PORQUE EN LA FORMA NATIVA ES UNA PROTEINA DE MEMBRANA INTEGRAL O COMPLEJO PROTEINICO. TAMBIEN SE PRESENTAN ANTIGENOS CARACTERIZADOS POR QUE POSEEN UNA ACTIVIDAD DEL TIPO DE LA PROTEINASA DE ASPARTILO Y/O DEL TIPO DE LA ENDOPEPTIDASA NEUTRA.
ES93916110T 1992-07-21 1993-07-20 Vacunas contra los parasitos metazoos. Expired - Lifetime ES2085163T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215505A GB9215505D0 (en) 1992-07-21 1992-07-21 Vaccines
GB929217635A GB9217635D0 (en) 1992-08-19 1992-08-19 Vaccines

Publications (1)

Publication Number Publication Date
ES2085163T3 true ES2085163T3 (es) 1996-05-16

Family

ID=26301293

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916110T Expired - Lifetime ES2085163T3 (es) 1992-07-21 1993-07-20 Vacunas contra los parasitos metazoos.

Country Status (20)

Country Link
EP (1) EP0652769B1 (es)
JP (1) JPH07509698A (es)
KR (1) KR950702435A (es)
CN (1) CN1088217A (es)
AT (1) ATE134878T1 (es)
AU (1) AU675443B2 (es)
CA (1) CA2140673A1 (es)
CZ (1) CZ14495A3 (es)
DE (1) DE69301733T2 (es)
ES (1) ES2085163T3 (es)
FI (1) FI950248A (es)
HU (1) HUT70985A (es)
IL (1) IL106407A (es)
MY (1) MY131433A (es)
NO (1) NO950211D0 (es)
NZ (1) NZ254210A (es)
PL (1) PL307170A1 (es)
TR (1) TR27329A (es)
WO (1) WO1994002169A1 (es)
ZW (1) ZW8893A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9303681D0 (en) * 1993-02-24 1993-04-14 Pitman Moore Inc Vaccines
GB9322702D0 (en) * 1993-11-03 1993-12-22 Agricultural & Food Res Vaccines
EP0804570A1 (en) * 1994-03-25 1997-11-05 Mallinckrodt Veterinary, Inc. Vaccines against helminthic parasites
GB9406708D0 (en) * 1994-04-05 1994-05-25 Mallinckrodt Veterinary Inc Vaccines
AU4624997A (en) * 1996-10-10 1998-05-05 Bayer Aktiengesellschaft Nematode proteins, dna sequences coding therefor, their specific antibodies and their use in identifying nematicidal active substances
KR100900837B1 (ko) 2007-12-07 2009-06-04 (주)두비엘 리포펩타이드와 폴리(ｉ:ｃ)를 아쥬반트로 포함하는 강력한백신 조성물
ES2441880B1 (es) * 2012-07-06 2014-11-13 Universidad De Granada Composición basada en polipéptidos para el tratamiento de miasis
CN103014173B (zh) * 2013-01-17 2014-04-16 福建出入境检验检疫局检验检疫技术中心 一种pcr检测鉴定盖罩大蜗牛的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8619293D0 (en) * 1986-08-07 1986-09-17 Munn E A Anthelmintic agents
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
US5525508A (en) * 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine

Also Published As

Publication number Publication date
IL106407A (en) 1997-09-30
EP0652769B1 (en) 1996-03-06
FI950248A0 (fi) 1995-01-20
JPH07509698A (ja) 1995-10-26
AU4579993A (en) 1994-02-14
KR950702435A (ko) 1995-07-29
IL106407A0 (en) 1993-11-15
AU675443B2 (en) 1997-02-06
NO950211L (no) 1995-01-20
WO1994002169A1 (en) 1994-02-03
TR27329A (tr) 1995-01-12
DE69301733T2 (de) 1996-10-31
CN1088217A (zh) 1994-06-22
NZ254210A (en) 1996-11-26
EP0652769A1 (en) 1995-05-17
ATE134878T1 (de) 1996-03-15
NO950211D0 (no) 1995-01-20
HU9500185D0 (en) 1995-03-28
HUT70985A (en) 1995-11-28
ZW8893A1 (en) 1994-06-01
MY131433A (en) 2007-08-30
PL307170A1 (en) 1995-05-15
FI950248A (fi) 1995-01-20
CZ14495A3 (en) 1995-09-13
CA2140673A1 (en) 1994-02-03
DE69301733D1 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
ES2170075T3 (es) Vacuna de proteina m recombinante multivalente.
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
ES487106A0 (es) Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
PT584348E (pt) Vacina genetica para virus da imunodeficiencia
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
ES2171454T3 (es) Proteinas de estres y sus usos.
ECSP066683A (es) Vacuna para mejorar el crecimiento, a base de epítopes neutralizantes
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
PE20011217A1 (es) Composicion farmaceutica para modulacion inmunologica y preparacion de vacunas
DE68927348T2 (de) Künstlicher impfstoff gegen aids-virus
MX9207113A (es) Fragmento de adn, peptido que comprende una proteina superficial ha de un virus de gripe a y vacuna que comprende tal peptido.
PE15297A1 (es) Proteinas anti-obesidad
CL2021001162A1 (es) Proteínas de fusión fc il-22 y métodos de uso. (divisional de solicitud 202001944)
ES2085163T3 (es) Vacunas contra los parasitos metazoos.
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
BR112022011099A2 (pt) Tratamento de doenças relacionadas ao vírus da hepatite b
AR245957A1 (es) Un dna recombinante que codifica para una proteina recombinante ligada a un soporte y un procedimiento para la fabricacion de la misma.
ES2069742T3 (es) Proteina de la capsida del calicivirus felino y secuencia nucleotida.
DE69508382D1 (de) Peptomere mit erhöhter immunogenizität
ES2090357T3 (es) Una proteina de union a colageno asi como su preparacion.
AR022662A1 (es) Acidos nucleicos y proteinas del gen mhp3 de mycoplasma hyopneumoniae y sus usos
ES2069574T3 (es) Vacuna contra el virus de la pseudorrabia.
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
NO881661D0 (no) Humane rhinoviruspeptider.
ES2042481T1 (es) Peptidos sinteticos que derivan del antigeno hbc del virus de la hepatitis b.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 652769

Country of ref document: ES